"Cognitive health platform Happyneuron gets majority ownership taken over by Raise Impact"
Raise Impact, a €260m impact investment fund, has acquired a majority stake in Happyneuron, an innovative online platform specializing in cognitive health assessment and rehabilitation. The investment aims to help Happyneuron continue its expansion in various markets, particularly in France where diagnosis for many cognitive disorders is slow due to high demand and limited availability.
Happyneuron's platform significantly improves the diagnostic process and enhances the precision and efficiency of care delivery. It offers 40 digital modules developed with medical professionals that assess and rehabilitate key cognitive functions, including language, hearing, neurological impairments, and mathematical cognition. This science-based, professional-designed approach helps practitioners identify cognitive issues more quickly and design targeted care plans, addressing long wait times for diagnoses—especially for disorders like dyslexia, dyspraxia, and dysphasia, where patients can otherwise wait up to a year to be seen.
The platform's tools can be used for diagnosing and treating a range of conditions, including stroke, traumatic brain injury, aphasia, ADHD, dementia, Alzheimer's, and more. More than 10,000 speech therapists have subscribed as users of Happyneuron's platform, and it has been adopted by hospitals and other healthcare professionals, including neuropsychologists and clinical psychologists. The investment will be used to grow Happyneuron's client base of healthcare practitioners.
Raise Impact's investment in Happyneuron is not just about financial growth. The managers of Raise Impact donate 50% of their carried interest to RAISE Sherpas, an internal endowment fund dedicated to supporting mission-driven startups and charitable associations. Moreover, Raise Group will help Happyneuron develop a structured approach to measure and manage its impact on improving patient care.
The Raise Impact fund focuses on taking active minority and majority controlling shares in European small and mid-cap growth companies, with ticket sizes ranging from €10m to €30m. The fund targets mission-driven companies that respond to challenges related to energy transition, agricultural transition, circular economy, and social inclusion. This investment in Happyneuron aligns with Raise Impact's mission to support companies that have a positive impact on society.
Bedrossian, a representative from Raise Impact, mentioned the possibility of acquisitions for Happyneuron in the future. The company generates 70% of its revenue from subscriptions to its platform, demonstrating a resilient business model with stable user retention. The platform has been launched in Luxembourg, Belgium, Switzerland, and North America, and the investment will undoubtedly propel Happyneuron towards further growth and impact in the field of cognitive disorder diagnosis and treatment.
[1] Source: Press Release, Raise Impact, [Date]
- The €260m impact investment fund, Raise Impact, aims to boost Happyneuron's growth across various markets, particularly France, through a majority stake acquisition in the online cognitive health platform.
- Happyneuron's science-based, professional-designed platform offers 40 digital modules developed with medical professionals, improving diagnostic accuracy and addressing long wait times for disorders like dyslexia and dysphasia.
- Raise Impact's investment in Happyneuron is not solely about financial growth; in addition to expanding the platform's user base of healthcare practitioners, the fund is committed to measuring and managing its impact on improving patient care.
- Raise Impact focuses on taking active minority and majority controlling shares in European small and mid-cap mission-driven companies, especially those addressing challenges related to energy transition, social inclusion, and health-and-wellness, which aligns with the fund's mission to support companies with a positive social impact.
- The investment in Happyneuron is expected to contribute to the growth and impact of the company in the field of cognitive disorder diagnosis and treatment, as it generates 70% of its revenue from subscriptions to its platform and has already been launched in multiple international markets.
- As part of the investment, Raise Impact donates 50% of its carried interest to RAISE Sherpas, an internal endowment fund dedicated to supporting mission-driven startups and charitable associations.
- Beyond finance and investing in businesses, Raise Impact's strategic approach extends to technology, fostering developments in areas like cognitive health, mental health, fitness-and-exercise, nutrition, and science, all while creating a positive social impact.
